Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.

Financial restrictions and a stronger focus on outcomes assessment require rational decisions regarding the allocation of resources in the health-care system. Such decisions are based on medical, ethical, and economic considerations. Management of the health-care system requires both a medical and an economic orientation at the overall societal level and regarding the selection of appropriate health-care services in hospitals and ambulatory practices. The practical application of health economic methods can be an important tool assuring more transparency and in validating necessary decisions.The methods made available by health economic research represent a rational approach for a structured resource allocation in the health-care system and facilitate the process of a relative assessment of various treatment methods with each other. Although the focus of such studies frequently rests on pharmaceuticals, health economic evaluation methods are suitable for all medical services, procedures, and health-care programs. But, what is assessed from which perspective,

Acquired haemophilia A (AHA) is a rare autoimmune disorder resulting from the formation of neutralizing antibodies against coagulation factor VIII (FVIII). 1,2 It is characterized by a sudden onset of bleeding in patients, who typically do not have a previous history of haemostasis disorder. Most patients present with severe

No abstract